Impact of 3-month earlier versus postponed initiation of opicapone versus entacapone in levodopa-treated patients with Parkinson's disease and motor fluctuations

被引：0
|
作者：
Carroll, C.
Lees, A.
Ferreira, J.
Fonseca, M.
Magalhaes, D.
Rocha, J.
Soares-da-Silva, P.
机构：
来源：
MOVEMENT DISORDERS | 2021年 / 36卷
关键词：
ADJUNCT;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
372
引用
收藏
页码：S164 / S164
页数：1
相关论文
共 50 条
  • [1] Impact of 3-month earlier versus later initiation of opicapone versus entacapone in levodopa-treated patients with Parkinson's disease and motor fluctuations
    Carroll, Camille
    Lees, Andrew
    Ferreira, Joaquim
    Fonseca, Miguel
    Magalhaes, Diogo
    Rocha, Jose
    Soares-Da-Silva, Patricio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 280 - 281
  • [2] Impact of 3-month early versus postponed initiation of opicapone vs entacapone in Parkinson's levodopa-treated patients
    Carroll, C.
    Lees, A.
    Ferreira, J.
    Fonseca, M.
    Magalhaes, D.
    Rocha, J-F
    Soares-da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 626 - 627
  • [3] Entacapone improves motor fluctuations in levodopa-treated Parkinson's disease patients
    Kieburtz, K
    Shoulson, I
    Fahn, S
    McDermott, M
    Koller, W
    LeWitt, P
    Nutt, J
    Kurth, M
    Brewer, M
    Lew, M
    Welsh, M
    Waters, C
    Bennett, J
    RostRuffner, E
    Feigin, A
    Gardiner, I
    Kurlan, R
    Hammerstad, J
    Stone, C
    Jankovic, J
    Beach, J
    Tetrud, J
    Kelker, K
    Standaert, DG
    Growdon, JH
    Tennis, M
    Graefe, K
    Mark, MH
    Kelly, SJ
    Pahwa, R
    McGuire, D
    Hubble, J
    Factor, SA
    Brown, DL
    Tuite, P
    Sime, E
    Lang, DL
    Greene, P
    Winfield, H
    Paulson, G
    Zoog, K
    Weeks, C
    Shults, C
    Fontaine, D
    Juncos, JL
    Wood, C
    Shannon, K
    Jaglin, JA
    Tornabene, J
    Lannon, MC
    ANNALS OF NEUROLOGY, 1997, 42 (05) : 747 - 755
  • [4] Early versus delayed initiation of entacapone in levodopa-treated patients with Parkinson's disease: a long-term, retrospective analysis
    Nissinen, H.
    Kuoppamaki, M.
    Leinonen, M.
    Schapira, A. H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (12) : 1305 - 1311
  • [5] The real-life effect of catechol-O-methyltransferase inhibition on non-motor symptoms in levodopa-treated Parkinson's disease: opicapone versus entacapone
    Leta, Valentina
    van Wamelen, Daniel J.
    Aureli, Federico
    Metta, Vinod
    Trivedi, Dhaval
    Cortelli, Pietro
    Rodriguez-Blazquez, Carmen
    Rizos, Alexandra
    Ray Chaudhuri, K.
    JOURNAL OF NEURAL TRANSMISSION, 2023, 130 (07) : 925 - 930
  • [6] The real-life effect of catechol-O-methyltransferase inhibition on non-motor symptoms in levodopa-treated Parkinson’s disease: opicapone versus entacapone
    Valentina Leta
    Daniel J. van Wamelen
    Federico Aureli
    Vinod Metta
    Dhaval Trivedi
    Pietro Cortelli
    Carmen Rodriguez-Blazquez
    Alexandra Rizos
    K. Ray Chaudhuri
    Journal of Neural Transmission, 2023, 130 : 925 - 930
  • [7] Effects of One-Day Application of Levodopa/Carbidopa/Entacapone versus Levodopa/Carbidopa/Opicapone in Parkinson's Disease Patients
    Mueller, Thomas
    Schlegel, Eugen
    Zingler, Stephanie
    Thiede, Hans Michael
    CELLS, 2022, 11 (09)
  • [8] Effect of opicapone and entacapone on daily pattern of motor fluctuations in Parkinson's disease patients
    Lees, A.
    Rascol, O.
    Ferreira, J.
    Klepitskaya, O.
    Fonseca, M.
    Magalhaes, D.
    Rocha, J. -F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2020, 35 : S461 - S461
  • [9] Opicapone as adjunctive therapy to levodopa in patients with Parkinson's disease and motor fluctuations: Global impressions of change compared to placebo and entacapone
    Santos, A.
    Ferreira, J.
    Lees, A.
    Pinto, R.
    Lopes, N.
    Nunes, T.
    Rocha, J. F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2015, 30 : S119 - S119
  • [10] Entacapone provides additional benefit to Parkinson's disease patients with motor fluctuations treated with levodopa and selegiline
    Larsen, J
    Nissinen, H
    Vahteristo, M
    MOVEMENT DISORDERS, 2005, 20 : S114 - S114
12345